Eosinophilic hepatitis after ingestion of choline magnesium trisalicylate.

Article Details

Citation

Nadkarni MM, Peller CA, Retig J

Eosinophilic hepatitis after ingestion of choline magnesium trisalicylate.

Am J Gastroenterol. 1992 Jan;87(1):151-3.

PubMed ID
1728115 [ View in PubMed
]
Abstract

Choline magnesium trisalicylate is a non-acetylated salicylate used widely as a nonsteroidal anti-inflammatory drug. Although mild transient hepatotoxicity associated with aspirin and other salicylates has been well documented, most commonly with high-dose treatment for rheumatologic disorders 112), we report a case of severe hypersensitivity hepatitis with striking tissue and peripheral eosinophilia after ingestion of choline magnesium trisalicylate.

DrugBank Data that Cites this Article

Drugs